Patents by Inventor Melissa CALTON

Melissa CALTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treatment of Ocular Disease Associated with Angiogenesis
    Publication number: 20240131195
    Abstract: The present disclosure provides compositions and methods for the treatment of ocular diseases associated with angiogenesis, particularly wet age-related macular degeneration.
    Type: Application
    Filed: October 5, 2023
    Publication date: April 25, 2024
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: Christian BURNS, Melissa CALTON, Meredith LEONG, Paul SZYMANSKI
  • ADENO-ASSOCIATED VARIANTS, FORMULATIONS AND METHODS FOR PULMONARY DELIVERY
    Publication number: 20240067987
    Abstract: The present disclosure provides a variant AAV capsid protein that confers tropism to lung cells and recombinant adeno-associated viruses comprising the variant A.AV and pharmaceutical compositions comprising same and their use in the delivery of heterologous nucleic acids to lung cells for the treatment of pulmonary disorders.
    Type: Application
    Filed: September 15, 2023
    Publication date: February 29, 2024
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: Melissa Kotterman, Peter Francis, Melissa Calton, Johnny Gonzales, Roxanne Croze, Christopher Schmitt
  • Adeno-associated variants, formulations and methods for pulmonary delivery
    Patent number: 11807868
    Abstract: The present disclosure provides a variant AAV capsid protein that confers tropism to lung cells and recombinant adeno-associated viruses comprising the variant AAV and pharmaceutical compositions comprising same and their use in the delivery of heterologous nucleic acids to lung cells for the treatment of pulmonary disorders.
    Type: Grant
    Filed: October 6, 2022
    Date of Patent: November 7, 2023
    Assignee: 4D Molecular Therapeutics Inc.
    Inventors: Melissa Kotterman, Peter Francis, Melissa Calton, Johnny Gonzales, Roxanne Croze, Christopher Schmitt
  • ADENO-ASSOCIATED VARIANTS, FORMULATIONS AND METHODS FOR PULMONARY DELIVERY
    Publication number: 20230257772
    Abstract: The present disclosure provides a variant AAV capsid protein that confers tropism to lung cells and recombinant adeno-associated viruses comprising the variant AAV and pharmaceutical compositions comprising same and their use in the delivery of heterologous nucleic acids to lung cells for the treatment of pulmonary disorders.
    Type: Application
    Filed: October 6, 2022
    Publication date: August 17, 2023
    Applicant: 4D Molecular Therapeutics Inc.
    Inventors: Melissa Kotterman, Peter Francis, Melissa Calton, Johnny Gonzales, Roxanne Croze, Christopher Schmitt
  • Adeno-associated variants, formulations and methods for pulmonary delivery
    Patent number: 11499166
    Abstract: The present disclosure provides a variant AAV capsid protein that confers tropism to lung cells and recombinant adeno-associated viruses comprising the variant AAV and pharmaceutical compositions comprising same and their use in the delivery of heterologous nucleic acids to lung cells for the treatment of pulmonary disorders.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: November 15, 2022
    Assignee: 4D Molecular Therapeutics Inc.
    Inventors: Melissa Kotterman, Peter Francis, Melissa Calton, Johnny Gonzales, Roxanne Croze, Christopher Schmitt
  • ADENO-ASSOCIATED VARIANTS, FORMULATIONS AND METHODS FOR PULMONARY DELIVERY
    Publication number: 20210395772
    Abstract: The present disclosure provides a variant AAV capsid protein that confers tropism to lung cells and recombinant adeno-associated viruses comprising the variant AAV and pharmaceutical compositions comprising same and their use in the delivery of heterologous nucleic acids to lung cells for the treatment of pulmonary disorders.
    Type: Application
    Filed: April 26, 2021
    Publication date: December 23, 2021
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: Melissa KOTTERMAN, Peter FRANCIS, Melissa CALTON, Johnny GONZALES, Roxanne CROZE, Christopher SCHMITT